# TomoTherapy

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/tomotherapy

- Industry: Healthcare
- Headquarters: Madison, US
- Website: www.tomotherapy.com
- Total disclosed funding: $1M
- Latest round: Series D (Jun 29, 2005)
- Investors on record: 1

## About

TomoTherapy specializes in advanced radiation therapy systems, focusing on the Radixact® System, which provides precise cancer treatment through innovative technology designed to optimize radiation delivery while minimizing side effects.TomoTherapy, founded in 1997 in Madison, US, is known for its development of the Radixact® System, a cutting-edge radiation therapy solution. The company raised USD 222.3 million in its IPO in May 2007 and completed a secondary offering later that year in October, raising approximately USD 189.125 million. The firm has participated in 8 deals, with its most recent deal on May 9, 2007, being a Private Placement/Follow on round.TomoTherapy offers advanced radiation therapy systems with its primary product, the Radixact® System. This system utilizes a unique helical treatment delivery method to provide accurate radiation treatment to cancer patients while minimizing damage to healthy tissues. The Radixact System is built on a CT scanner foundation, ensuring high precision in radiation dosage. The company serves hospitals and cancer treatment centers worldwide, focusing on various cancer types to enhance treatment efficacy.In the most recent year, 2010, TomoTherapy generated revenue of USD 195.36 mn, with an EBITDA of USD -28.64 mn. The company primarily earns revenue through direct sales of the Radixact System and related support services, establishing ongoing relationships with healthcare providers.Looking ahead, TomoTherapy aims to introduce new products and expand its market presence. The company plans to enhance its Radixact System with new features and expects to target growth in North America, Europe, and Asia by 2025. Recent funding has been allocated to support these initiatives, following its IPO in 2007, which raised significant capital to bolster its operational capacity and product development.

## Funding rounds

- Series D, Jun 29, 2005, $1M — Ascension Ventures

## Investors

- Ascension Ventures (https://capitalatlas.ai/funds/ascension-ventures) — Series D